Strata Critical Medical, Inc. (SRTA)

Strata Critical Medical Statistics

Total Valuation

SRTA has a market cap or net worth of $361.91 million. The enterprise value is $254.06 million.

Market Cap	361.91M
Enterprise Value	254.06M

Important Dates

The next confirmed earnings date is Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

SRTA has 81.70 million shares outstanding. The number of shares has increased by 5.12% in one year.

Current Share Class	81.70M
Shares Outstanding	81.70M
Shares Change (YoY)	+5.12%
Shares Change (QoQ)	+1.76%
Owned by Insiders (%)	13.26%
Owned by Institutions (%)	56.71%
Float	57.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.45
Forward PS	1.41
PB Ratio	1.70
P/TBV Ratio	2.17
P/FCF Ratio	n/a
P/OCF Ratio	277.37
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.95, with a Debt / Equity ratio of 0.04.

Current Ratio	5.95
Quick Ratio	5.38
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -8.39% and return on invested capital (ROIC) is -4.45%.

Return on Equity (ROE)	-8.39%
Return on Assets (ROA)	-4.00%
Return on Invested Capital (ROIC)	-4.45%
Return on Capital Employed (ROCE)	-7.43%
Revenue Per Employee	$820,455
Profits Per Employee	-$61,235
Employee Count	310
Asset Turnover	0.95
Inventory Turnover	n/a

Taxes

Income Tax	-219,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.98
52-Week Price Change	n/a
50-Day Moving Average	4.91
200-Day Moving Average	n/a
Relative Strength Index (RSI)	37.67
Average Volume (20 Days)	745,578

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SRTA had revenue of $254.34 million and -$18.98 million in losses. Loss per share was -$0.24.

Revenue	254.34M
Gross Profit	62.14M
Operating Income	-17.21M
Pretax Income	-19.20M
Net Income	-18.98M
EBITDA	-10.93M
EBIT	-17.21M
Loss Per Share	-$0.24

Balance Sheet

The company has $113.42 million in cash and $8.84 million in debt, giving a net cash position of $104.58 million or $1.28 per share.

Cash & Cash Equivalents	113.42M
Total Debt	8.84M
Net Cash	104.58M
Net Cash Per Share	$1.28
Equity (Book Value)	223.10M
Book Value Per Share	2.73
Working Capital	130.17M

Cash Flow

In the last 12 months, operating cash flow was $1.29 million and capital expenditures -$18.81 million, giving a free cash flow of -$17.52 million.

Operating Cash Flow	1.29M
Capital Expenditures	-18.81M
Free Cash Flow	-17.52M
FCF Per Share	-$0.21

Margins

Gross margin is 24.43%, with operating and profit margins of -6.77% and -7.46%.

Gross Margin	24.43%
Operating Margin	-6.77%
Pretax Margin	-7.55%
Profit Margin	-7.46%
EBITDA Margin	-4.30%
EBIT Margin	-6.77%
FCF Margin	n/a

Dividends & Yields

SRTA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.12%
Shareholder Yield	-5.12%
Earnings Yield	-5.29%
FCF Yield	-4.89%

Analyst Forecast

The average price target for SRTA is $7.25, which is 63.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.25
Price Target Difference	63.66%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SRTA has an Altman Z-Score of 5.01 and a Piotroski F-Score of 4.

Altman Z-Score	5.01
Piotroski F-Score	4